Document is current
Any future updates will be listed below
-
Authors
Lazarus, Jeffrey V. https://orcid.org/0000-0001-9618-2299
Mark, Henry E. https://orcid.org/0000-0002-8022-4279
Anstee, Quentin M. https://orcid.org/0000-0002-9518-0088
Arab, Juan Pablo https://orcid.org/0000-0002-8561-396X
Batterham, Rachel L.
Castera, Laurent https://orcid.org/0000-0002-6715-8588
Cortez-Pinto, Helena https://orcid.org/0000-0002-8537-8744
Crespo, Javier https://orcid.org/0000-0001-8248-0172
Cusi, Kenneth
Dirac, M. Ashworth
Francque, Sven https://orcid.org/0000-0002-7527-4714
George, Jacob https://orcid.org/0000-0002-8421-5476
Hagström, Hannes
Huang, Terry T.-K. https://orcid.org/0000-0001-5544-5187
Ismail, Mona H. https://orcid.org/0000-0001-6371-3997
Kautz, Achim
Sarin, Shiv Kumar https://orcid.org/0000-0002-0544-5610
Loomba, Rohit https://orcid.org/0000-0002-4845-9991
Miller, Veronica
Newsome, Philip N.
Ninburg, Michael https://orcid.org/0000-0001-8592-5878
Ocama, Ponsiano
Ratziu, Vlad
Rinella, Mary
Romero, Diana https://orcid.org/0000-0002-4832-9564
Romero-Gómez, Manuel https://orcid.org/0000-0001-8494-8947
Schattenberg, Jörn M. https://orcid.org/0000-0002-4224-4703
Tsochatzis, Emmanuel A.
Valenti, Luca
Wong, Vincent Wai-Sun https://orcid.org/0000-0003-2215-9410
Yilmaz, Yusuf https://orcid.org/0000-0003-4518-5283
Younossi, Zobair M.
Zelber-Sagi, Shira
,
Åberg, Fredrik
Adams, Leon
Khatry, Maryam Salem Al
Naamani, Khalid Al
Murillo, Omar Alfaro
Allen, Alina M.
Alnaser, Faisal
Alqahtani, Saleh A.
Alswat, Khalid
Alvaro, Domenico
Andrade, Raúl J.
Arrese, Marco
Awuku, Yaw Asante
Ayesha, Motala
Baatarkhuu, Oidov
Bakieva, Shokhista
Basu, Rita
Bataller, Ramon
Bedri, Shahinaz
Bosi, Emanuele
Bourliere, Marc
Bruha, Radan
Bugianesi, Elisabetta
Burra, Patrizia
Buti, Maria
Byrne, Christopher D.
Calleja, Jose Luis
Carrieri, Patrizia
Carter, Flloyd
Fernandez, Marlen Ivon Castellanos
Castillo-Lopez, Gabriela
Castro-Narro, Graciela E.
Chan, Henry Lik Yuen
Chan, Wah-Kheong
Chang, Yoosoo
Colombo, Massimo
Coppell, Kirsten J.
Corey, Kathleen
Craxi, Antonio
Cryer, Donna
Dassanayake, Anuradha
Martins, Antonieta de Ascenção Soares
de Ledinghen, Victor
DelPrato, Stefano
Demaio, Alessandro
Desalegn, Hailemichael
Dillon, John
Duseja, Ajay
Dorairaj, Prabhakaran
Ekstedt, Mattias
El Kassas, Mohamed
Elsanousi, Osama M.
Esmat, Gamal
Fan, Jian-Gao
Farpour-Lambert, Nathalie
Flisiak, Robert
Fouad, Yasser
Fuchs, Michael
Gani, Rino A.
Gerber, Lynn
Ghazinyan, Hasmik
Gheorghe, Liana
Goh, George Boon-Bee
Grønbæk, Henning
Gulnara, Aghayeva
Hamid, Saeed
Hebditch, Vanessa
Hickman, Ingrid J.
Hocking, Samantha L.
Hunyady, Bela
Idilman, Ramazan
Isakov, Vasily A.
Jamal, Mohammad H.
Jepsen, Peter
Iskandar, Natacha Jreige
Song, Myeong Jun
Sudhamshu, K. C.
Kakizaki, Satoru
Kalamitsis, George
Kanwal, Fasiha
Kao, Jia-Horng
Kaplan, Lee
Kawaguchi, Takumi
Khader, Yousef
Kim, Seung Up
Kodjoh, Nicolas
Koek, Ger
Koike, Kazuhiko
Komas, Narcisse Patrice
Korenjak, Marko
Kugelmas, Marcelo
Labidi, Asma
Lange, Naomi F.
Lavine, Joel E.
Lazo, Mariana
Lee, Nancy
Lesmana, Cosmas Rinaldi A.
Liu, Chun-Jen
Long, Michelle T.
Lopez-Jaramillo, Patricio
Malekzadeh, Reza
Mahtab, Mamun Al
Marchesini, Giulio
Marinho, Rui
Vázquez, Sophia E. Martínez
Mateva, Lyudmila
Nlombi, Charles Mbendi
Melin, Pascal
Mikolasevic, Ivana
Milovanovic, Tamara
Musso, Carla
Nakajima, Atsushi
Nava, Edna
Nersesov, Alexander V.
Nikolova, Dafina
Norris, Suzanne
Novak, Katja
Oben, Jude
Ong, Janus P.
Onyekwere, Charles
Papatheodoridis, George
Paruk, Imran
Patel, Keyur
Macedo, M. Paula
Penha-Gonçalves, Carlos
Figueroa, Marlene Pérez
Hofmann, Wolf Peter
Petta, Salvatore
de Oliveira, Claudia Pinto Marques Souza
Puri, Puneet
Pan, Calvin Q.
Rac, Marek
Ralston, Johanna
Ramji, Alnoor
Razavi, Homie
Alvares-da-Silva, Mario Reis
Roberts, Stuart
Roden, Michael
Rose, Tamsin
Rouabhia, Samir
Rovere-Querini, Patrizia
Rowe, Ian A.
Sadirova, Shakhlo
Salupere, Riina
Saparbu, Tobokalova
Sayegh, Raymond
Sebastiani, Giada
Seki, Yosuke
Selmo, Josefina
Serme, Abdel Karim
Shaw, Jonathan E.
Shenoy, Thrivikrama
Sheron, Nick
Shibolet, Oren
Silva, Marcelo
Skrypnyk, Igor
Socha, Piotr
Soriano, Joan
Spearman, C. Wendy
Sridharan, Kannan
Suárez, Juan José
Sheriff, Dhastagir Sultan
Sung, Ki-Chul
Swain, Mark
Tacke, Frank
Taheri, Shahrad
Tan, Soek-Siam
Tapper, Elliot B.
Yki-Järvinen, Hannele
Thiele, Maja
Shawa, Isaac Thom
Tolmane, Ieva
Torres, Esther A.
Trauner, Michael
Treeprasertsuk, Sombat
Turcanu, Adela
Valantinas, Jonas
Vesterhus, Mette
Waked, Imam
Wild, Sarah H.
Willemse, Jose
Wong, Robert J.
Xanthakos, Stavra
Young, Dan Yock
Yu, Ming-Lung
Zheng, Kenneth I.
Zeybel, Mudjat
Zheng, Ming-Hua
- License Information
-
More Information
Article History
Accepted: 2 September 2021
First Online: 27 October 2021
Change Date: 17 November 2021
Change Type: Update
Change Details: The formatting of Mohamed El Kassas’ name in the xml was incorrect, resulting in El being wrongly classed as a given name and not part of their surname. This has now been corrected online and in print.
Competing interests
: A.K. declares grants/contracts from Intercept and Novartis and conference support from Intercept. E.A.T. has received personal fees from Intercept, Gilead, Pfizer and Promethera, and honoraria from Intercept, Gilead and Pfizer. E.A.T. is a member of the Governing Board of the European Association for the Study of the Liver. H.C.-P. has received honoraria from Intercept and Novo Nordisk. H.H. has received grants or contracts from Intercept, AstraZeneca, MSD, Pfizer, EchoSens, Stockholm City Council, Swedish Cancer Foundation, Radiumhemmets Forskningsfonder, Julins Fond, Stockholm Innovation Foundation, Skandia Research Foundation, Åke Wiberg Foundation, Bengt Ihre Foundation and Tore Nilson Foundation, participated on an advisory board for BMS and Gilead, and has stock or stock options in Novo Nordisk. H.E.M. has received grants to EASL International Liver Foundation to support NAFLD activities from Intercept, Genfit, BMS and MSD. J.C. reports consultant and/or speaker and/or participated in clinical trials sponsored by and/or received grants and research support from Gilead Sciences, AbbVie, MSD, Shionogi, Intercept Pharmaceuticals, Janssen Pharmaceuticals, Celgene and Alexion (all outside the submitted work). J.M.S. declares a research grant from Gilead; consulting fees from Boehringer Ingelheim, BMS, Genfit and Gilead, Intercept Pharmaceuticals, Madrigal, Novartis, Novo Nordisk, Nordic Bioscience, Pfizer, Roche, Sanofi, Siemens Healthcare GmbH; speakers bureau from Falk Foundation, and MSD Sharp & Dohme. J.V.L. reports grants, personal fees and other support from AbbVie, personal fees from CEPHEID, personal fees from Genfit, grants, personal fees and other support from Gilead Sciences, personal fees from GSK, personal fees from Intercept, personal fees from Janssen, and grants and personal fees from MSD, outside the submitted work. L.C. declares: grants from Gilead; speaker’s bureau for Abbvie, Echosens, Gilead, Intercept, Novo Nordisk; has been a member of an advisory board for Allergan, Alexion, Echosens, Gilead, Intercept, MSD, Novo Nordisk, Pfizer and Servier. L.V. declares grants or contracts from Gilead; honoraria from MSD, Gilead, AlfaSigma and Abbvie; support for attending conferences from Gilead; participation on advisory or safety boards for Intercept, Pfizer and Gilead. M.N. has received unrestricted research grants from Gilead, Abbie and Merck, and was President of the World Hepatitis Alliance 2018–2020. M.R. has received honoraria from Alnylam, Amgen, AMRA, BMS, Boehringer Ingelheim, Centara, Coheres, Enanta, Galecto, Intercept, Madrigal, NGM Biopharmaceuticals, Novo Nordisk, Pfizer, Fractyl, Gelesis, Siemens, Thetis, Terns, Rivus, 3vBio (Sagimet), 89bio, Novartis, Immuron, Merck and Taiwan J Pharmaceuticals. M.R.-G. reports grants from Intercept, grants from Gilead Sciences, personal fees from Shionogi, personal fees from Alfa Wassermann, personal fees from ProSciento, personal fees from Kaleido, personal fees from Novo Nordisk, personal fees from MSD, personal fees from BMS, personal fees from Allergan, personal fees from Boehringer Ingelheim, personal fees from Zydus, personal fees from Intercept Pharma and personal fees from Gilead Science, outside the submitted work. Q.M.A. declares grant funding from multiple EFPIA partners via the EU IMI2-funded consortium Litmus (Abbvie, Antaros Medical, Allergan/Tobira, AstraZeneca, BMS, Boehringer Ingelheim International, Echosens, Ellegaard Gottingen Minipigs, Eli Lilly & Company, Exalenz Bioscience Ltd., Genfit, Glympse Bio, GlaxoSmithKline, HistoIndex, Intercept Pharma Europe Ltd., iXscient Ltd., Nordic Bioscience, Novartis Pharma AG, Novo Nordisk A/S, One Way Liver Genomics SL, Perspectum Diagnostics, Pfizer Ltd., Resoundant, Sanofi-Aventis Deutschland GmbH, SomaLogic Inc., Takeda Pharmaceuticals International SA.); grants from Glympse Bio; royalties/licences from Elsevier; consulting fees from Allergan, AstraZeneca, Blade Therapeutics, BMS, Cirius Therapeutics, CymaBay, Eli Lilly, Galmed, Genfit, Gilead, HistoIndex, Intercept, Inventiva, Madrigel, Metacrine, NGMBio, Novartis, Novo Nordisk, Pfizer, Poxel Pharma and The Medicines Company; honoraria from MedScape and Fishawack; and participation on safety or advisory boards for North Sea Therapeutics and Medpace. R.L.B. declares grants or contracts from Novo Nordisk and GLWL Research; consulting fees (personal) from Novo Nordisk, Viiv, Boehringer Ingelheim and International Medical Press; has participated on safety or advisory boards for Novo Nordisk and Pfizer; has been an unpaid trustee of the Association for the Study of Obesity, BOMMS Council Member and Trustee of Obesity Empowerment Network UK. R.L. declares grants or contracts from Allergan, AstraZeneca, Boehringer-Ingelheim, Bristol-Myers Squibb, Eli Lilly, Galectin Therapeutics, Galmed Pharmaceuticals, Genfit, Gilead, Intercept, Inventiva, Janssen, Madrigal Pharmaceuticals, Merck, NGM Biopharmaceuticals, Pfizer and Sonic Incytes; consulting fees from Aardvark Therapeutics, Altimmune, Anylam/Regeneron, Amgen, Arrowhead Pharmaceuticals, AstraZeneca, Bristol-Myers Squibb, CohBar, Eli Lilly, Galmed, Gilead, Glympse bio, Hightide, Inipharm, Intercept, Inventiva, Ionis, Janssen Inc., Madrigal, Metacrine, Inc., NGM Biopharmaceuticals, Novartis, Novo Nordisk, Merck, Pfizer, Sagimet, Theratechnologies, 89bio and Viking Therapeutics; and is co-founder of Liponexus. S.F. declares grants or contracts from Gilead, Roche, Bristol-Myers Squibb and Genfit; consulting fees from Roche, Gilead, Allergan, Abbvie, Bayer, Bristol-Myers Squibb, Boehringer Ingelheim, Merck Sharp & Dohme, Janssen, Actelion, Astellas, Genfit, Inventiva, Intercept, Echosense, Genentech, Novo Nordisk, Novartis, AstraZeneca, Galmed, Promethera, Coherus, Madrigal, Julius Clinical, NGM Bio; and honoraria from Gilead, Genfit, Bayer, Abbvie, Intercept, Allergan. V.M. declares unrestricted contributions to the Liver Forum. V.R. declares grants or contracts from Gilead; consulting fees from Novo Nordisk, Galmed, Madrigal, AstraZeneca, Intercept, Terns, Theratechnologies, NGM, Bristol-Myers Squibb; and support for attending meetings from Gilead. V.W.-S.W. declares grants or contracts from Gilead (to institution); consulting fees and participation on boards (personal) from 3V-BIO, AbbVie, Allergan, Boehringer Ingelheim, Center for Outcomes Research in Liver Diseases, Echosens, Gilead Sciences, Hanmi Pharmaceutical, Intercept, Inventiva, Merck, Novartis, Novo Nordisk, Perspectum Diagnostics, Pfizer, ProSciento, Sagimet Biosciences, TARGET PharmaSolutions and Terns; honoraria (personal) from Abbott, AbbVie, Bristol-Myers Squibb, Echosens, Gilead Sciences; and support for attending meetings or travel (institution) from Abbvie and Gilead. Y.Y. declares research grants from Biocordex and Gilead; honoraria from Gilead, Bilim, Pharmactive, Sanovel and Echosens; and participated on advisory boards for Novo Nordisk and Abbvie. J.P.A., K.C., M.A.D., J.G., T.T.-K.H, M.H.I., P.N.N., P.O., D.R., S.K.S., S.Z.-S. and Z.M.Y. declare no competing interests.
Free to read: This content has been made available to all.
